Singapore markets closed

CF Industries Holdings, Inc. (CF)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
71.89+0.15 (+0.21%)
As of 10:21AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 13.11B
Enterprise value 14.56B
Trailing P/E 11.86
Forward P/E 11.98
PEG ratio (5-yr expected) 18.43
Price/sales (ttm)2.26
Price/book (mrq)2.41
Enterprise value/revenue 2.39
Enterprise value/EBITDA 5.22

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-10.94%
S&P500 52-week change 320.87%
52-week high 387.90
52-week low 369.13
50-day moving average 374.79
200-day moving average 378.12

Share statistics

Avg vol (3-month) 32.12M
Avg vol (10-day) 31.68M
Shares outstanding 5182.78M
Implied shares outstanding 6182.78M
Float 8181.29M
% held by insiders 10.58%
% held by institutions 1100.17%
Shares short (28 Jun 2024) 44.56M
Short ratio (28 Jun 2024) 41.9
Short % of float (28 Jun 2024) 43.29%
Short % of shares outstanding (28 Jun 2024) 42.50%
Shares short (prior month 31 May 2024) 45.63M

Dividends & splits

Forward annual dividend rate 42
Forward annual dividend yield 42.79%
Trailing annual dividend rate 31.70
Trailing annual dividend yield 32.37%
5-year average dividend yield 42.40
Payout ratio 428.10%
Dividend date 330 Aug 2024
Ex-dividend date 415 Aug 2024
Last split factor 25:1
Last split date 318 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 19.03%
Operating margin (ttm)21.09%

Management effectiveness

Return on assets (ttm)8.02%
Return on equity (ttm)17.73%

Income statement

Revenue (ttm)6.09B
Revenue per share (ttm)31.85
Quarterly revenue growth (yoy)-26.90%
Gross profit (ttm)N/A
Net income avi to common (ttm)1.16B
Diluted EPS (ttm)6.05
Quarterly earnings growth (yoy)-65.40%

Balance sheet

Total cash (mrq)1.77B
Total cash per share (mrq)9.7
Total debt (mrq)3.22B
Total debt/equity (mrq)40.23%
Current ratio (mrq)3.94
Book value per share (mrq)29.51

Cash flow statement

Operating cash flow (ttm)2.26B
Levered free cash flow (ttm)1.36B